{"id":"https://openalex.org/W2257530665","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.4087","title":"Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)","display_name":"Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)","publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W2257530665","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.4087","mag":"2257530665"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.27.15_suppl.4087","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.4087","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.4087","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062202820","display_name":"Neil Howard Segal","orcid":"https://orcid.org/0000-0002-3047-2303","observed_orcids":["https://orcid.org/0000-0002-3047-2303"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. H. Segal","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032598163","display_name":"Diane L. Reidy\u2010Lagunes","orcid":"https://orcid.org/0000-0003-2688-4556","observed_orcids":["https://orcid.org/0000-0003-2688-4556"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Reidy-Lagunes","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045756365","display_name":"Marinela Capanu","orcid":"https://orcid.org/0000-0003-4953-3193","observed_orcids":["https://orcid.org/0000-0003-4953-3193"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Capanu","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069644669","display_name":"Nancy E. Kemeny","orcid":"https://orcid.org/0000-0002-0929-9542","observed_orcids":["https://orcid.org/0000-0002-0929-9542"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Kemeny","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019666497","display_name":"Ki Young Chung","orcid":"https://orcid.org/0000-0001-6586-2013","observed_orcids":["https://orcid.org/0000-0001-6586-2013"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Chung","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069929201","display_name":"David Paul Kelsen","orcid":"https://orcid.org/0000-0001-6139-438X","observed_orcids":["https://orcid.org/0000-0001-6139-438X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Kelsen","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090149957","display_name":"Ellen M. Hollywood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Hollywood","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062744135","display_name":"Noah Goodman-Davis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Goodman-Davis","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037120205","display_name":"Leonard B. Saltz","orcid":"https://orcid.org/0000-0001-8353-4670","observed_orcids":["https://orcid.org/0000-0001-8353-4670"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. B. Saltz","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"15_suppl","first_page":"4087","last_page":"4087"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":1.0},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.890999972820282},{"id":"https://openalex.org/keywords/irinotecan-refractory-disease","display_name":"irinotecan-refractory disease","score":0.9330000281333923},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.5720000267028809},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.6330000162124634},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.593999981880188},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.6859999895095825},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7860000133514404},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6779999732971191},{"id":"https://openalex.org/keywords/hypomagnesemia","display_name":"hypomagnesemia","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9417816996574402},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.7892881035804749},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7346339225769043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6963682174682617},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6363645792007446},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5559661984443665},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5490503907203674},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5382139086723328},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5273674130439758},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.5070748329162598},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3865465819835663},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33258554339408875},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28960102796554565},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22803592681884766}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2009.27.15_suppl.4087","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.4087","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.4087","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2476532096","https://openalex.org/W4206310290","https://openalex.org/W3004763000","https://openalex.org/W2106656437","https://openalex.org/W2068448950","https://openalex.org/W2248738797","https://openalex.org/W2891817128","https://openalex.org/W2278432427","https://openalex.org/W2472670411","https://openalex.org/W2138628633"],"abstract_inverted_index":{"4087":[0],"Background:":[1],"We":[2],"previously":[3,71,295],"showed":[4],"that":[5],"adding":[6],"bevacizumab":[7],"(bev)":[8],"to":[9,30,51,59,82,117,206,266,302,334],"cetuximab":[10],"(cetux)":[11],"plus":[12,61,129],"irinotecan":[13],"(IRI)":[14],"in":[15,64,219,291,316],"bev-na\u00efve,":[16],"IRI-refractory":[17],"CRC":[18,43,68,323],"patients":[19,44,65,79,232,292],"is":[20],"feasible,":[21],"and":[22,28,97,111,199,229,286,311],"yielded":[23],"a":[24,47,173,203,209,347],"favorable":[25],"response":[26,284,309],"rate":[27,310],"time":[29],"tumor":[31],"progression":[32,345],"(TTP)":[33],"compared":[34],"with":[35,66,233,289],"historical":[36],"controls":[37],"(Saltz:":[38],"JCO,":[39],"2007).":[40],"Since":[41],"most":[42],"now":[45],"receive":[46],"bev-containing":[48,348],"regimen":[49],"prior":[50,116,157],"cetux,":[52],"we":[53,223],"evaluated":[54],"the":[55,93,108,273,278,283,307,317,337],"addition":[56],"of":[57,86,156,175,213,280,321,339,342],"bev":[58,298,343],"cetux":[60],"IRI":[62,106],"(CBI)":[63],"metastatic":[67],"who":[69,293],"had":[70,202],"progressed":[72,296],"on":[73,297,346],"chemo":[74],"+":[75],"bev.":[76],"Methods:":[77],"All":[78],"were":[80],"na\u00efve":[81],"cetux.":[83,207],"The":[84,261],"importance":[85],"KRAS":[87],"mutation":[88],"was":[89,95,150,159,166,242,252,264],"not":[90,100,300],"appreciated":[91],"when":[92],"trial":[94,320],"designed":[96],"this":[98],"has":[99],"yet":[101],"been":[102,270],"evaluated.":[103],"Patients":[104,171],"received":[105,115,146,172],"at":[107,126],"same":[109],"dose":[110],"schedule":[112],"as":[113,304,306],"last":[114],"study,":[118],"Cetux":[119],"400":[120],"mg/m2":[121],"loading":[122],"dose,":[123],"then":[124],"weekly":[125],"250":[127],"mg/m2,":[128],"Bev":[130],"5":[131],"mg/kg":[132,139],"given":[133,140],"every":[134,141],"two":[135],"weeks":[136],"or":[137],"7.5":[138],"three":[142],"weeks.":[143],"Results:":[144],"33":[145,220],"treatment.":[147],"Median":[148,154,163,240,250],"age":[149],"58":[151],"(range":[152,161,169,178,216],"29\u201385).":[153],"number":[155],"regimens":[158],"2":[160,176,319],"1\u20132).":[162],"performance":[164],"status":[165],"ECOG":[167],"1":[168],"0\u20131).":[170],"median":[174,210],"cycles":[177],"1\u201315).":[179],"Grade":[180],"3/4":[181],"Toxicities:":[182],"Acneiform":[183],"Rash":[184],"18%,":[185],"hypomagnesemia":[186],"6%,":[187,189],"hypophosphatemia":[188],"Neutropenia":[190],"15%,":[191],"Diarrhea":[192],"6%.":[193],"One":[194],"patient":[195,201],"developed":[196],"neutropenic":[197],"fever":[198],"one":[200],"hypersensitivity":[204],"reaction":[205],"At":[208],"follow":[211],"up":[212],"32":[214],"months":[215,244,254,313],"21\u201332":[217],"months)":[218],"evaluable":[221],"patients,":[222],"observed":[224],"3":[225],"(9%)":[226],"partial":[227],"responses":[228],"11":[230],"(33%)":[231],"stable":[234],"disease":[235],"for":[236],">":[237],"4":[238],"months.":[239],"TTP":[241,287,314],"3.9":[243],"(95%":[245,255],"CI:":[246,256],"1.3":[247],"-":[248,258],"6.8).":[249],"survival":[251],"10.6":[253],"6.6":[257],"13.8).":[259],"Conclusions:":[260],"toxicity":[262],"profile":[263],"similar":[265],"what":[267],"would":[268],"have":[269,294],"expected":[271],"from":[272],"individual":[274],"agents":[275],"alone.":[276],"Recognizing":[277],"limitations":[279],"cross-study":[281],"comparisons,":[282],"rates":[285],"seen":[288,315],"CBI":[290],"do":[299],"appear":[301],"be":[303,332],"encouraging":[305],"37%":[308],"7.3":[312],"BOND":[318],"bev-na\u00efve":[322],"patients.":[324],"Ongoing":[325],"randomized":[326],"trials,":[327],"including":[328],"SWOG":[329],"0600,":[330],"will":[331],"needed":[333],"definitively":[335],"determine":[336],"contribution":[338],"continued":[340],"use":[341],"after":[344],"regimen.":[349],"Supported":[350],"by":[351],"Genentech.":[352],"[Table:":[353],"see":[354],"text]":[355]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}